Friulimicin A, a formidable antibiotic widely employed in the biomedicine sector, showcases its prowess in fierce bacterial infection warfare. Its efficacy reaches paramount heights primarily against the relentless onslaught of Gram-positive bacteria, triumphing even over those harbouring resistant properties. Fathomably distinctive in its modus operandi, Friulimicin A emerges as the panacea for diverse maladies inflicted by bacterial pathogens, spanning cutaneous afflictions, respiratory dilemmas, and urogenital predicaments.
CAT# | R1987 |
CAS | 302327-40-8 |
M.F/Formula | C58H92N14O19 |
M.W/Mr. | 1289.43 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Since the discovery of Substance P (SP) in the early 1930s, its pharmacological actions have been extensively studied. SP has ...
Propofol, known as 2,6-Diisopropyl phenol, is mainly used in the induction and maintenance of general anesthesia ...
NoxA1ds is derived from a peptide whose structure is based on a short sequence of an essential Nox subunit. It b ...
In the respiratory tract, there are tachykinin P (SP) and neurokinin A (NKA) in capsaicin-sensitive primary affe ...
GRK2i, a GRK2 inhibitory polypeptide, specifically inhibits Gβγ activation of GRK2. It corresponds to the Gβγ-bi ...